Huons Global Co. Ltd (084110) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.027x

Based on the latest financial reports, Huons Global Co. Ltd (084110) has a cash flow conversion efficiency ratio of 0.027x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩30.10 Billion ≈ $20.40 Million USD) by net assets (₩1.10 Trillion ≈ $742.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Huons Global Co. Ltd to measure how much of total assets are equity-financed.

Huons Global Co. Ltd - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Huons Global Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Huons Global Co. Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Huons Global Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Huons Global Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Twelve Seas Investment Co II
NASDAQ:TWLV
-0.001x
Critical Holdings Berhad
KLSE:0291
-0.070x
Karyopharm Therapeutics Inc
NASDAQ:KPTI
0.040x
MIRC Electronics Limited
NSE:MIRCELECTR
-0.387x
Compania Espanola de Viviendas en Alquiler SA
MC:CEV
0.006x
JIUMAOJIU INTL HLDGS LTD
F:3YU
N/A
Taylor Devices Inc
NASDAQ:TAYD
0.013x
Summit Securities Limited
NSE:SUMMITSEC
0.011x

Annual Cash Flow Conversion Efficiency for Huons Global Co. Ltd (2010–2025)

The table below shows the annual cash flow conversion efficiency of Huons Global Co. Ltd from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Huons Global Co. Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩1.09 Trillion
≈ $739.51 Million
₩93.61 Billion
≈ $63.44 Million
0.086x -55.64%
2024-12-31 ₩520.11 Billion
≈ $352.47 Million
₩100.57 Billion
≈ $68.16 Million
0.193x +76.15%
2023-12-31 ₩910.68 Billion
≈ $617.15 Million
₩99.97 Billion
≈ $67.75 Million
0.110x -19.15%
2022-12-31 ₩464.32 Billion
≈ $314.66 Million
₩63.04 Billion
≈ $42.72 Million
0.136x +46.56%
2021-12-31 ₩537.84 Billion
≈ $364.49 Million
₩49.82 Billion
≈ $33.76 Million
0.093x -57.79%
2020-12-31 ₩412.83 Billion
≈ $279.77 Million
₩90.59 Billion
≈ $61.39 Million
0.219x +26.73%
2019-12-31 ₩378.53 Billion
≈ $256.52 Million
₩65.55 Billion
≈ $44.42 Million
0.173x +17.42%
2018-12-31 ₩362.21 Billion
≈ $245.47 Million
₩53.42 Billion
≈ $36.20 Million
0.147x +5.87%
2017-12-31 ₩341.14 Billion
≈ $231.19 Million
₩47.52 Billion
≈ $32.20 Million
0.139x +129.81%
2016-12-31 ₩319.80 Billion
≈ $216.72 Million
₩19.38 Billion
≈ $13.14 Million
0.061x -79.89%
2015-12-31 ₩168.94 Billion
≈ $114.49 Million
₩50.91 Billion
≈ $34.50 Million
0.301x +97.16%
2014-12-31 ₩188.38 Billion
≈ $127.66 Million
₩28.79 Billion
≈ $19.51 Million
0.153x -22.72%
2013-12-31 ₩125.24 Billion
≈ $84.87 Million
₩24.77 Billion
≈ $16.79 Million
0.198x +2.71%
2012-12-31 ₩92.92 Billion
≈ $62.97 Million
₩17.89 Billion
≈ $12.13 Million
0.193x +125.39%
2010-12-31 ₩78.18 Billion
≈ $52.98 Million
₩6.68 Billion
≈ $4.53 Million
0.085x --

About Huons Global Co. Ltd

KQ:084110 Korea Pharmaceuticals
Market Cap
$177.18 Million
₩261.45 Billion KRW
Market Cap Rank
#16986 Global
#627 in Korea
Share Price
₩24100.00
Change (1 day)
-1.03%
52-Week Range
₩22550.00 - ₩75300.00
All Time High
₩75300.00
About

Huons Global Co., Ltd. provides medical solutions for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and inj… Read more